Last updated on May 2019

Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis


Brief description of study

The purpose of this study is to determine whether etrasimod is a safe and effective treatment for moderately to severely active ulcerative colitis.

Clinical Study Identifier: NCT03945188

Find a site near you

Start Over

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.